Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.790
-0.040 (-2.19%)
Jan 13, 2026, 3:30 PM EST - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $11.02 million as of January 13, 2026. Its market cap has decreased by -65.89% in one year.
Market Cap
11.02M
Enterprise Value
1.21M
1-Year Change
-65.89%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $11.02M, a decrease of -98.25%. That is a compound annual growth rate of -56.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 11.26M | 10.91% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |